🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Effects of Post-Isometric Relaxation and Myofascial Release on Low Back Pain With Lower Cross Syndrome

RecruitingNAAges 18 Years - 45 YearsAllUniversity of Karachi
NCT07496099 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

This randomized controlled trial aims to evaluate the combined effects of post-isometric relaxation and myofascial release on pain, flexibility, and functional disability in individuals with low back pain associated with lower cross syndrome. Eligible participants aged 18 to 45 years will be randomly allocated into two parallel intervention groups. One group will receive post-isometric relaxation combined with myofascial release, while the comparison group will receive conventional stretching combined with Therapeutic modalities. Outcomes will be assessed at baseline and after completion of the intervention period. The results of this study are expected to contribute to evidence-based physiotherapy management of low back pain associated with postural imbalance.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: 1. Participants aged 18-45 years old 2. having low back pain persisting for at least 4 weeks 3. with clinical diagnosis of LCS, and hamstring tightness (AKE \>15°) Exclusion Criteria: 1. Participants with the history of spinal surgery active neurological conditions 2. systemic disease affecting connective tissue (Rheumatoid arthritis, Systemic lupus erythematosus) 3. recent lower limb or spinal injury (within 6 months) 4. pregnancy or inability to lie prone for treatment.
💊

What it tests

  • post isometric relaxation
  • MYOFASCIAL RELEASE
  • Conventional Static Stretching
  • Therapeutic Modalities
📍

Where

1 site
life cure physiotherapy clinic malir cantt, Karachi
Karachi, Pakistan
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy